Dag-uman, Paul .
HRN: 24-56-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/06/2025
11/13/2025
IVTT
90mg
Q6
Preseptal Vs Periorbital Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes